CBD Research

Highlights •CBD is a beneficial immune regulator in TMEV-IDD model, with long-term effects. •CBD treatment improves motor deficits in the chronic phase of TMEV-IDD. •CBD decreases VCAM-1, CCL2/CCL5 chemokines and TNFα/IL-1β. •Adenosine A2A receptors mediate some of the CBD effects both in vivo and in...

Considerable evidence demonstrates that manipulation of the endocannabinoid system reduces nausea and vomiting in humans and other animals.     Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system. Eur J Pharmacol. 2014 Jan 5;722:134-46. doi: 10.1016/j.ejphar.2013.09.068. Epub 2013 Nov 1. https://www.ncbi.nlm.nih.gov/pubmed/24184696   Cannabidiol, a non-psychotropic component of cannabis, attenuates...

The risk of bladder cancer A study on the association between cannabis use and the risk of bladder cancer shows strong evidence that cannabis can potentially kill cancer: An analysis of 84,170 participants looked at the association between cannabis use and the occurrence of bladder cancer. Over 16 years, they...

Neuroprotection is the mechanisms and strategies used to protect against neuronal injury or degeneration in the Central Nervous System following acute disorders (e.g. stroke or nervous system injury/trauma) or as a result of chronic neurodegenerative diseases (e.g. Parkinson's, Alzheimer's, Multiple Sclerosis).   Sources: Neuroprotective antioxidants from marijuana. Ann N...

A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis   The present study was designed to investigate the efficacy of a new formulation of alone, purified cannabidiol (CBD) (>98 %), the main non-psychotropic cannabinoid of Cannabis sativa, as a...

Receive Discounts & Breaking CBD Research
Home | Sitemap